Product Revenue -- $44 million, representing 9% of total revenue and increasing 22.3% on a year-over-year basis, with the ...
I'm Vince Ippolito, Executive Chairman of the Board of Botanix Pharmaceuticals Limited, and we're pleased to present the Botanix quarterly activity report and 4C quarterly cash flow report for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results